12/3
09:19 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/3
09:19 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
12/3
07:19 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
12/3
07:19 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
12/3
06:19 am
vrdn
Viridian Therapeutics initiated with an Outperform at William Blair
Low
Report
Viridian Therapeutics initiated with an Outperform at William Blair
12/3
06:19 am
vrdn
Viridian Therapeutics initiated with an Outperform at William Blair
Low
Report
Viridian Therapeutics initiated with an Outperform at William Blair
12/3
06:13 am
vrdn
Viridian Therapeutics initiated with an Outperform at William Blair
Low
Report
Viridian Therapeutics initiated with an Outperform at William Blair
12/3
06:13 am
vrdn
Viridian Therapeutics initiated with an Outperform at William Blair
Low
Report
Viridian Therapeutics initiated with an Outperform at William Blair
11/6
11:29 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
11/6
11:29 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
11/4
08:09 am
vrdn
Viridian Therapeutics (NASDAQ:VRDN) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $61.00 price target on the stock.
Low
Report
Viridian Therapeutics (NASDAQ:VRDN) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $61.00 price target on the stock.
11/4
05:14 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
10/21
09:32 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
10/21
09:32 am
vrdn
Rating for VRDN
Low
Report
Rating for VRDN